E. Ohman J:Or Asset Management Ab Nkarta, Inc. Transaction History

E. Ohman J:Or Asset Management Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 05, 2024	SELL	$5.14 - $14.35 $479,495 - $1.34 Million	-93,287 Closed	0 $0
Q3 2022 Apr 05, 2024	SELL	$12.27 - $18.39 $203,473 - $304,961	-16,583 Reduced 15.09%	93,287 $1.23 Billion
Q2 2022 Apr 05, 2024	SELL	$7.77 - $19.44 $331,825 - $830,204	-42,706 Reduced 27.99%	109,870 $1.35 Billion
Q1 2022 Apr 05, 2024	BUY	$8.66 - $14.99 $472,628 - $818,094	54,576 Added 55.69%	152,576 $1.74 Billion
Q4 2021 Apr 05, 2024	BUY	$12.79 - $26.88 $1.25 Million - $2.63 Million	98,000 New	98,000 $1.5 Billion

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $114M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.